Add to Google
Date :
Time :
Advertising : Place your textual ad here - Latest News headlines : First Human Embryonic Stem Cell Lines Approved for Use Under New NIH Guidelines - PPD Launches New Global Biostatistics Technology Infrastructure - Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain -
  Print



Lawsuit Claims Celgene Corporation Misappropriated the Idea Behind its Multiple Myeloma Treatments

By Beth R Jacobson
Publication date : Wednesday, 26 August 2009

Beth R. Jacobson Claims She Developed the Idea for Treatment of Multiple Myeloma with Thalidomide, seeks at least 25% of the profits from sale of THALOMID(R) and REVLIMID(R). Beth R. Jacobson (formerly Beth R. Wolmer) filed suit yesterday against Celgene Corporation (Nasdaq: CELG), under the claims of "misappropriation of an idea" and "unjust enrichment" regarding the Company's sale of thalidomide (THALOMID(R) and REVLIMID(R)) for the treatment of multiple myeloma. The suit alleges that Ms. Jacobson developed the original and novel idea for treating

multiple myeloma with thalidomide and is therefore entitled to compensation consistent with established legal precedent. Ms. Jacobson is represented in this suit by Goodwin Procter LLP.

The suit, which was filed in U.S. District Court in Newark, New Jersey, seeks a minimum of $300 million as past damages and 25 percent of the future profits resulting from the sale of Celgene's thalidomide products (THALOMID(R) and REVLIMID(R)) for the treatment of multiple myeloma.

Want to read more?

The Future Of Biopharma
SAFC Biosciences(R) Defines Hydrolysate Components
The Zimmer Institute Redefines Industry-driven Training

NEW SERVICE !
pharmaceutical press release publication
PRODUCT AWARD


PERSPECTIVES



OFFICIAL PARTNERS
ICSE Partner

PMEC Partner

Bio Manufacturing Summit Partner

American Conference Institute Partner

WTP partner

NEW! Send your Press Release for publication - Related Pharmaceutical websites : Asia Manufacturing Pharma | Pharmaceutical Manufacturing News
Pharmaceutical packaging | APIs | Excipients | Generics | Processing | Outsourcing | QA/QC | Pharma Strategy | Drug Discovery | Biotechnology | Clinical Dev.
Subscribe to Asia-Lifesiences.com | Unsubscribe from Asia-Lifesiences.com | Advertise | Privacy Statement | Copyright | Contact the publisher of this site

© Intelligent Publishing Media 2009 - All rights reserved.